Research output per year
Research output per year
Search results
-
2023
Genomic analysis of Mycobacterium brumae sustains its nonpathogenic and immunogenic phenotype
Renau-Mínguez, C., Herrero-Abadía, P., Ruiz-Rodriguez, P., Sentandreu, V., Torrents, E., Chiner-Oms, Á., Torres-Puente, M., Comas, I., Julián, E. & Coscolla, M., 5 Jan 2023, In: Frontiers in Microbiology. 13, 19 p., 982679.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
2022
Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN-γ/IL-17 release in bladder cancer treatment
Guallar Garrido, S., Campo Pérez, V., Perez-Trujillo, M., Cabrera Navarro, C., Senserrich, J., Sánchez Chardi, A. D., Rabanal Prados, R. M., Gómez-Mora, E., Noguera Ortega, E., Luquin Fernandez, M. D. L. M. & Julian Gomez, E., 2022, In: OncoImmunology. 11, 1, 15 p., 2051845.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Citations (Scopus) -
2021
Analysis of the lipid composition of mycobacteria by thin layer chromatography
Guallar-Garrido, S., Luquin, M. & Julián, E., 16 Apr 2021, In: Journal of Visualized Experiments. 2021, 170, e62368.Research output: Contribution to journal › Article › Research › peer-review
6 Citations (Scopus) -
Easily applicable modifications to electroporation conditions improve the transformation efficiency rates for rough morphotypes of fast-growing mycobacteria
Campo-Pérez, V., Cendra, M. D. M., Julián, E. & Torrents, E., 25 Jul 2021, In: New Biotechnology. 63, p. 10-18 9 p.Research output: Contribution to journal › Article › Research › peer-review
4 Citations (Scopus) -
2020
Each Mycobacterium Requires a Specific Culture Medium Composition for Triggering an Optimized Immunomodulatory and Antitumoral Effect
Guallar-Garrido, S., Campo-Pérez, V., Sánchez-Chardi, A., Luquin Fernández, M. & Julián, E., 14 May 2020, In: Microorganisms. 8, 5, 16 p., 734.Research output: Contribution to journal › Article › Research › peer-review
Open Access6 Citations (Scopus) -
Mycolicibacterium brumae is a safe and non-toxic immunomodulatory agent for cancer treatment
Bach-Griera, M., Campo-Pérez, V., Barbosa, S., Traserra, S., Guallar-Garrido, S., Moya-Andérico, L., Herrero-Abadía, P., Luquin, M., Rabanal, R. M., Torrents, E. & Julián, E., 25 Apr 2020, In: Vaccines. 8, 2, 198.Research output: Contribution to journal › Article › Research › peer-review
Open Access10 Citations (Scopus)